Skip to content
Explore innovative ideas and motivational stories at Bold C…

Individuals Discontinuing Weight-Loss Injections Put On Weight Far More Rapidly Compared to Dieters

Illustration of medical syringe and scale
Weight management involves long-term strategies.

Fresh analysis suggests that patients who stop using new slimming jabs like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who stop traditional lifestyle regimens.

Findings released in a major medical journal points out that while obese individuals can lose about a fifth of their total mass while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.

"Individuals buying these medications must be informed of the potential of quick rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb.

Such speed of regain suggests a return to pre-treatment mass within about a year and a half.

Comparing Treatments

The analysis, which reviewed 37 of trials involving thousands of patients, compared the results of GLP-1 agonists with other pills.

Researchers point out that people who shed pounds through lifestyle changes alone typically see a slower weight regain—perhaps 0.1 kg a month—post-intervention.

The Reason for the Fast Rebound

Doctors propose the mechanism of the drugs accounts for the accelerated rebound.

GLP-1 drugs mimic a natural hormone called GLP-1, which helps regulate appetite.

"Sustained high doses of the hormone concentrations far above than normal could lead to the body to produce less of its endogenous GLP-1, and could diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics expert.

"Discontinuation of this hormone supplement means appetite is uncontrolled, making binge eating a significant risk."

An Ongoing Condition?

Health authorities recommend the injections for individuals with obesity-related health risks, accompanied by prescribed diet and exercise modifications.

Many experts argue that, considering the likelihood of relapse, the therapy might need to be life-long.

This opinion is echoed by drug manufacturers, who say that the results "underscore the chronic nature of obesity," similar to managing diseases like diabetes.

Patient Experiences

People who have stopped the jabs explain a powerful return of appetite.

"It was like something flipping and you become starving," described a patient.

This difficulty is worsened if individuals have not developed lasting lifestyle or habit changes during therapy.

Widespread Use

Recent estimates suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with interest being substantial.

  • Use is greater among females compared to males.
  • The 40s and 50s age group shows the highest usage rates.
  • Many obtain the drugs through private prescriptions rather than public health services.

Finally, clinicians emphasize that while these medications are powerful agents for weight loss, they are not a magic fix and long-term success likely depends on integrated behavioural changes.

About the author

Joshua Taylor

A digital storyteller and innovation enthusiast, sharing insights on creativity and modern life.

Bold Club Station

Type to search articles.